Human Health - Serving Patients 

Improving the quality of life of our patients through innovative treatment options. 

At Boehringer Ingelheim (Canada) Ltd./Ltée, we are committed to providing our customers with innovative medicines to improve their health and quality of life. We strongly believe in creating value through innovation and are constantly looking for new ways to better the well-being of our customers and the health care system with new pharmaceutical products. 

We focus on researching and developing new drugs and treatments that represent major therapeutic advances. We are a proven leader in respiratory healthcare. However, recent research has resulted in the development of treatments for a diverse range of medical conditions. 

Today, we offer therapeutic options for diseases and conditions such as chronic obstructive pulmonary disease (COPD), high blood pressure, stroke, depression, benign prostatic hyperplasia (BPH), Parkinson's disease, HIV/AIDS, complications of blood clotting, restless leg syndrome (RLS) and continue extensive research in cancer, virology, stroke prevention in atrial fibrillation, diabetes and respiratory diseases. 

Disclaimer 

This section provides information on specific disease states and is intended for Canadian residents only. It is important that consumers rely on the advice of a health care professional to employ good clinical judgement for the specific conditions of individual patients. This information is not intended to be a substitute for the advice of a health care professional or a recommendation for any particular treatment plan. Please consult your physician for professional advice pertaining to a particular disease state.